Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CTLA4 dimorphisms and the multiple sclerosis phenotype.

Thomas Masterman1, Arturs Ligers, Zhiping Zhang

  • 1Department of Neurology, Karolinska Institutet at Huddinge University Hospital, S-141 86, Stockholm, Sweden. Thomas.Masterman@neurotec.ki.se

Journal of Neuroimmunology
|November 30, 2002
PubMed
Summary

Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene variations were studied in multiple sclerosis (MS). Haplotypes showed initial associations with disease course, but these were not confirmed in a second study phase.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.

Journal of neurology·2026
Same author

A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.

European journal of epidemiology·2026
Same author

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

Acta neuropathologica·2026
Same author

Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis.

European journal of neurology·2026
Same author

Correction to: Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study.

European journal of clinical pharmacology·2026

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Autoimmune Disease Research

Background:

  • Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is a key regulator of T-cell activation and immune tolerance.
  • CTLA-4 signaling downregulates T-cell clonal expansion, playing a critical role in preventing autoimmunity.
  • A single-nucleotide polymorphism (SNP) in the CTLA4 exon 1 gene has been linked to susceptibility in autoimmune diseases like multiple sclerosis (MS).

Purpose of the Study:

  • To investigate the influence of CTLA4 haplotypes, combining exon 1 and promoter-region SNPs, on multiple sclerosis.
  • To determine if these CTLA4 haplotypes affect age at onset, disease severity, and disease course in MS patients.

Main Methods:

  • A two-stage genetic association study design was employed.

Related Experiment Videos

  • Haplotype analysis was performed using alleles from a CTLA4 exon 1 SNP and a promoter-region SNP.
  • Patient subgroups were analyzed based on disease course, age at onset, and severity.

    • Main Results:

    • Stage 1 revealed significant deviations in CTLA4 haplotype frequencies among MS patients when subgrouped by disease course.
    • However, these observed associations did not reach statistical significance or were not replicated in Stage 2 of the study.
    • The study did not confirm a link between the investigated CTLA4 haplotypes and specific clinical parameters of MS.

    Conclusions:

    • While initial findings suggested a potential role for CTLA4 haplotypes in MS disease course, these associations were not robustly confirmed.
    • Further research may be needed to explore other genetic factors or environmental influences on multiple sclerosis pathogenesis and progression.